Soluble CD146, a novel endothelial marker, is related to the severity of liver disease

Abstract

sCD146 can be used as a surrogate, inexpensive biomarker for the diagnosis of cirrhosis. It is also well correlated with severity of liver disease in cirrhotic patients. Further studies are needed to define its role in clinical practice.